APSR2026-515

Yes
Late-Breaking
Submitted
Oral Presentation
AO01-003
 
 
https://storage.unitedwebnetwork.com/files/1285/1220744-46903-APSR-515_final_439866.pptx
Format: PPTX Only
 
Format: PDF Only
09. Asthma
9

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Kosuke Makita * The University of Tokyo Department of Respiratory Medicine, Graduate School of Medicine Tokyo Japan McGill University Health Centre and McGill University Meakins–Christie Laboratories Montreal Canada
Toby McGovern - McGill University Health Centre and McGill University Meakins–Christie Laboratories Montreal Canada
Bowen Zhao - McGill University Health Centre and McGill University Meakins–Christie Laboratories Montreal Canada
Jun Ding - McGill University Health Centre and McGill University Meakins–Christie Laboratories Montreal Canada
Yumiko Ishii - McGill University Health Centre and McGill University Meakins–Christie Laboratories Montreal Canada
Utako Fujii - McGill University Health Centre and McGill University Meakins–Christie Laboratories Montreal Canada
Daniel Pyo - McGill University Health Centre and McGill University Meakins–Christie Laboratories Montreal Canada
Rui Sun - McGill University Health Centre and McGill University Meakins–Christie Laboratories Montreal Canada
James Martin - McGill University Health Centre and McGill University Meakins–Christie Laboratories Montreal Canada
 
 
 
 
 
 
Presenting Author Details
Kosuke
Makita
truenorth0214@gmail.com
+817085266681
41-50
Japan
Original Research
Dual role of the EGFR in airway dysfunction and epithelial regeneration in mice following chlorine exposure
Maximum 25 words
Abstract Content
Chlorine (Cl₂) is a common cause of irritant-induced asthma (IIA), a predominantly neutrophilic, T2-low phenotype with few targeted therapies. While epidermal growth factor receptor (EGFR) signaling regulates epithelial repair and inflammation in allergic asthma, its role in Cl₂-induced airway injury and dysfunction remains undefined. Here, we investigated the specific contribution of EGFR to airway dysfunction and epithelial regeneration following Cl₂ exposure in mice.
Wild-type BALB/c mice were exposed to Cl₂ gas and treated with the EGFR tyrosine kinase inhibitors (TKIs) gefitinib or afatinib. Airway hyperresponsiveness (AHR) to methacholine was assessed using the flexiVent system. We evaluated bronchoalveolar lavage (BAL) fluid cytokines (CXCL1, IL-6, IL-33), BAL cellularity, and epithelial apoptosis (TUNEL) and proliferation (Ki-67). Lung EGFR pathway activation (p-EGFR, p-STAT3, p-ERK, p-Akt) and NRF2 nuclear translocation were analyzed via immunoblotting and immunostaining. A STAT3 inhibitor was utilized to dissect IL-6/STAT3 contributions. RNA sequencing of lung tissue was performed to identify global transcriptomic alterations associated with EGFR inhibition.
Cl₂ rapidly increased EGFR ligands (HB-EGF, amphiregulin) and induced EGFR activation in the lungs. EGFR inhibition significantly attenuated AHR and reduced pro-inflammatory cytokines (CXCL1, IL-6, IL-33) in BAL fluid, though it did not decrease total inflammatory cell counts. While afatinib suppressed downstream STAT3/ERK/Akt phosphorylation, direct STAT3 blockade reduced BAL cellularity without improving AHR, indicating that EGFR-dependent AHR modulation is not solely explained by the IL-6/STAT3 axis. Notably, EGFR inhibition impaired NRF2 nuclear translocation, suppressing antioxidant responses (Hmox1, Nfe2l2) and prolonging epithelial apoptosis. Transcriptomic analysis revealed that EGFR inhibition altered pathways linked to muscle contraction and extracellular matrix remodeling.
EGFR plays a distinct dual role in Cl₂-induced airway injury. While its inhibition beneficially attenuates AHR and cytokine production, it simultaneously impairs NRF2-mediated oxidative defenses and delays epithelial repair. These findings highlight the complex mechanistic landscape of EGFR signaling in irritant-induced asthma and suggest that therapeutic targeting requires careful consideration of this dual function.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Epidermal growth factor receptor (EGFR), Irritant-induced asthma, Airway hyperresponsiveness
maximum 3 keywords and no abbreviations, separated by commas
 
315